Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Becton, Dickinson and Company (BDX:NYSE), powered by AI.
Becton, Dickinson and Company is currently trading at $146.24. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Becton, Dickinson and Company on Alpha Lenz.
Becton, Dickinson and Company's P/E ratio is 25.1.
“Becton, Dickinson and Company trades at a P/E of 25.1 (premium valuation) with modest ROE of 6.5%.”
Ask for details →Becton, Dickinson and Company, commonly known as BD, is a prominent American multinational corporation engaged in the development and manufacture of a diverse range of medical devices, instrument systems, and reagents. A key player in the healthcare industry, BD focuses on improving medical discovery, diagnostics, and the delivery of care. BD's products are instrumental in supporting healthcare professionals worldwide in enhancing patient safety and reducing the risks associated with healthcare workers. The company operates across three main segments: BD Medical, BD Life Sciences, and BD Interventional, impacting various sectors such as pharmaceuticals, hospital healthcare systems, and clinical laboratories. With a strong commitment to innovation and quality, Becton, Dickinson and Company contributes significantly to advancements in patient care, operating efficiency in medical settings, and is noted for its commitment to addressing healthcare challenges on a global scale. Headquartered in Franklin Lakes, New Jersey, BD maintains a robust presence across numerous countries, underpinning its influential role in the evolution and improvement of global healthcare infrastructure.
“Becton, Dickinson and Company trades at a P/E of 25.1 (premium valuation) with modest ROE of 6.5%.”
Ask for details →Becton, Dickinson and Company (ticker: BDX) is a company listed on NYSE in the Healthcare sector (Medical Instruments & Supplies). It has approximately 70,000 employees. Market cap is $42.1B.
The current price is $146.24 with a P/E ratio of 25.07x and P/B of 1.66x.
ROE is 6.54% and operating margin is 13.67%. Annual revenue is $21.8B.